Daily as of 3 Nov 16:00 ET
- Price
- above both $66.40 vs 50 $60.48 / 200 $53.49
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 4 Feb 2025 · projected 27 bars out
RPRX | Royalty Pharma plc Class ANASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$66.40
-$0.12 (-0.18%)
Royalty Pharma plc Class A (RPRX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA sits above the 200 on the daily, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $67.18 vs 50 $51.02 / 200 $36.18
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 17 Nov 2025 · projected 29 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- above both $67.20 vs 50 $60.75 / 200 $58.91
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 24 Jan 2025 · projected 22 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| week of 17 Nov 2025 | 🟨Golden moderate | weekly | 29 bars out | Not tested |
| 4 Feb 2025 | 🟨Golden | daily | 27 bars out | Not tested |
| 24 Jan 2025 | 🟨Golden | 4-hour | 22 bars out | — |
| 5 Nov 2024 | 💀Death | 4-hour | 22 bars out | — |
| 15 Aug 2024 | 🟨Golden | 4-hour | 9 bars out | — |
About RPRX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$167M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge